Umdlavuza we-pancreatic uthinta abantu baseMelika ababalelwa ku-60,000 unyaka ngamunye futhi ungenye yezinhlobo zomdlavuza ezibulala kakhulu. Ngemuva kokuxilongwa, iziguli ezingaphansi kuka-10% zingaphila iminyaka emihlanu.

Nakuba enye i-chemotherapy iqala ukusebenza, izimila zama-pancreas zivame ukumelana nazo. Amaqiniso afakazele ukuthi lesi sifo kunzima futhi ukuselapha ngezindlela ezintsha ezifana ne-immunotherapy.

Ithimba labacwaningi be-MIT manje selithuthukise isu le-immunotherapy futhi labonisa ukuthi lingaqeda izimila ze-pancreatic kumagundane.

Lokhu kwelashwa okusha kuyinhlanganisela yemithi emithathu esiza ukuthuthukisa ukuzivikela komzimba ngokumelene nezimila futhi kulindeleke ukuthi ingene ezivivinyweni zomtholampilo ngasekupheleni kwalo nyaka.

Uma le ndlela ingaveza impendulo ehlala njalo ezigulini, izoba nomthelela omkhulu ezimpilweni okungenani zeziguli ezithile, kodwa sidinga ukubona ukuthi isebenza kanjani ngempela ovivinyweni.